XML 70 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Note 12 - Share Capital (Tables)
12 Months Ended
Nov. 30, 2023
Statement Line Items [Line Items]  
Disclosure of reserves within equity [text block]
  

Restricted Shares
($)

  

Share Options
($)

  

Warrants
($)

  

Total
($)

 

Balance at November 30, 2021

  37   6,529   3,541   10,107 

Options exercised

  -   (429)  -   (429)

Restricted share rights vested

  (140)  -   -   (140)

Share-based compensation

  138   2,254   -   2,392 

Balance at November 30, 2022

  35   8,354   3,541   11,930 

Options exercised

  -   (805)  -   (805)

Restricted share rights vested

  (416)  -   -   (416)

Share-based compensation

  381   2,403   -   2,784 

Balance at November 30, 2023

  -   9,952   3,541   13,493 
Disclosure of number and weighted average exercise prices of share options [text block]
  

Number of

Options

  

Weighted

Average

Exercise Price

($)

 

Balance at November 30, 2021

  12,444,150   1.63 

Granted

  4,694,445   1.61 

Exercised(1)

  (705,520)  1.58 

Cancelled/Forfeited

  (175,000)  2.01 

Expired

  (2,255,000)  1.70 

Balance at November 30, 2022

  14,003,075   1.61 

Granted

  3,700,000   1.10 

Exercised(2)

  (2,377,000)  0.92 

Cancelled/Forfeited

  (17,500)  1.83 

Expired

  (363,380)  1.45 

Balance at November 30, 2023

  14,945,195   1.60 
Disclosure of indirect measurement of fair value of goods or services received, share options granted during period [text block]
  

November 30,

2023

  

November 30,

2022

 

Risk-free interest rate

  4.18%  3.54%

Expected life (years)

  2.87   2.87 

Expected volatility

  52.75%  61.25%

Expected dividend yield

  0.00%  0.00%

Estimated forfeiture rate

  3.00%  2.87%
Disclosure of range of exercise prices of outstanding share options [text block]
  

Options Outstanding

  

Options Exercisable

 

Exercise

Prices

 

Number of

Options

Outstanding

  

Weighted

Average

Exercise

Price

($)

  

Weighted

Average

Remaining

Contractual

Life

(years)

  

Number of

Options

Exercisable

  

Weighted Average Exercise

Price

($)

  

Weighted

Average

Remaining

Contractual

Life

(years)

 

$0.78 - $1.08

  2,134,500   1.05   0.70   2,134,500   1.05   0.70 

$1.09 - $1.59

  3,955,000   1.12   4.81   1,178,750   1.16   4.57 

$1.60 - $1.82

  4,083,000   1.60   3.98   3,046,625   1.60   3.98 

$1.83 - $2.00

  2,657,695   1.83   2.95   2,657,695   1.83   2.95 

$2.01 - $3.38

  2,115,000   2.77   2.01   2,115,000   2.77   2.01 
   14,945,195   1.60   3.27   11,132,570   1.73   2.80 
Restricted share rights [member]  
Statement Line Items [Line Items]  
Disclosure of number and weighted average exercise prices of other equity instruments [text block]
  

Number of

RSRs

  

Weighted Average Value

($)

 

Balance at November 30, 2021

  62,500   2.04 

Granted

  239,490   1.60 

Vested

  (72,564)  1.94 

Balance at November 30, 2022

  229,426   1.61 

Granted

  403,700   1.23 

Vested

  (266,596)  1.56 

Balance at November 30, 2023

  366,530   1.23